An Integrated Approach

At Savonix, we believe there is no mental health or physical health – there is just health.

Our CEO, Mylea Charvat, has a personal connection to dementia. When she was 13 years old, Mylea watched as her smart, spirited grandmother slowly began to lose her memory and her ability to care for herself. The experience profoundly shaped Mylea and laid the foundation for her life’s mission to understand the brain and how it works. Enter Savonix.

With our community of leading scientists, Savonix developed a mobile neurocognitive assessment and brain health platform. Clinically validated and used by patients, clinicians, and insurers worldwide, our platform allows end users to screen for cognitive health directly from their mobile device. Built specifically for mobile, it ensures precise reaction time within milliseconds, which guarantees more accurate cognitive data results.

With Savonix, individuals, employers, healthcare systems, researchers, and providers access accurate cognitive data in domains from attention and impulse control to different kinds of memory to assess for dementia risk. We create evidence-based clinical care plans at the touch of a button — fully customized to an individual’s healthcare needs.

Our Core Values


“I joined Savonix to create products that will improve the health and education of our users.”

Andrewnet C.
Product Designer

Our Philosophy — The Fifth Vital Sign

To Savonix, cognition represents the fifth vital sign and is as important to measure regularly as blood pressure, temperature, pulse, and breathing rate. We make this possible. We provide our customers with comprehensive data and insights around brain health and lifestyle to inspire patient behavior change.

Our big vision? A world without dementia. We deliver improved classification and diagnosis of different types of dementia to ultimately drive prevention and novel therapeutics.


Dr. Mylea Charvat
CEO & Founder
Dan Kogan
Chief Technology Officer
Pin Chin Kwok
Chief Business Officer and President Of Asia-Pacific
Kelly Benning
VP, Sales and Marketing
Dr. Simon Collinson
Chief Science Officer

Join us on the journey to better cognitive health.
Find out more about our Digital Cognitive Assessment Platform, learn more about us, or read the latest news.

Contact us

Savonix in the News

The Funded: New Bay Area IPO filings, $60M in funding deals
August 29, 2019
Savonix adds another $9.6M for cognitive assessment app
April 25, 2019
Women in IT Awards Asia 2019: shortlist revealed for inaugural awards
May 29, 2019